Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nautilus Biotechnology, Inc. - SIC # 3827 - OPTICAL INSTRUMENTS AND LENSES
Ticker
Exchange
SIC #
Website
Latest Ticker
NAUT
Nasdaq
3827
www.nautilus.bio
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nautilus Biotechnology, Inc.
3 Promising Penny Stocks With Market Caps Up To $900M
- May 5th, 2026 6:05 am
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans
- May 5th, 2026 5:05 am
Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
- Apr 29th, 2026 1:05 am
Nautilus Biotechnology Q1 Earnings Call Highlights
- Apr 28th, 2026 9:29 am
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
- Apr 28th, 2026 6:00 am
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy
- Apr 13th, 2026 11:59 pm
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
- Apr 9th, 2026 6:00 am
Q1 Virtual Investor Summit Presentations Now Available On Demand
- Mar 26th, 2026 1:46 pm
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year
- Mar 25th, 2026 5:08 pm
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist
- Mar 25th, 2026 6:05 am
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
- Mar 24th, 2026 6:00 am
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
- Mar 20th, 2026 6:00 am
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
- Mar 18th, 2026 6:00 am
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
- Mar 2nd, 2026 6:00 am
Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary
- Feb 26th, 2026 6:07 pm
Nautilus Biotechnology Q4 Earnings Call Highlights
- Feb 26th, 2026 3:48 pm
Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ...
- Feb 26th, 2026 2:07 pm
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
- Feb 26th, 2026 6:00 am
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
- Feb 24th, 2026 6:00 am
Jefferies Upgrades BETA Technologies, Inc. (BETA) to Buy
- Feb 21st, 2026 7:41 pm
Scroll